Início/Ações/NPCE

NPCE

USD

Neuropace Inc. Common Stock

$11.230-0.570 (-4.831%)

Preço em tempo real

Healthcare

Dispositivos médicos

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$11.800

Máximo

$12.032

Mínimo

$11.110

Volume

0.24M

Fundamentos da empresa

Capitalização de mercado

368.3M

Setor

Dispositivos médicos

País

United States

Estatísticas de negociação

Volume médio

0.29M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $5.45Atual $11.230Máximo $18.975

Notícias relacionadas

4/06/2025 · 20:09

GlobeNewswire

NeuroPace Secures Up to $75 Million in Debt Financing

MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has

Ver mais

NeuroPace Secures Up to $75 Million in Debt Financing

28/05/2025 · 10:27

Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On NeuroPace with Buy Rating, Announces Price Target of $18

HC Wainwright & Co. analyst Yi Chen initiates coverage on NeuroPace with a Buy rating and announces Price Target of $18.

Ver mais

HC Wainwright & Co. Initiates Coverage On NeuroPace with Buy Rating, Announces Price Target of $18

27/05/2025 · 12:00

GlobeNewswire

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week

Ver mais